Incretin Mimetics Market, By Drug Type (Exenatide, Liraglutide, Sitagliptin, Saxagliptin, Alogliptin , Others), By Disease Indication (Type 2 Diabetes Mellitus (T2DM) , Weight Management , Others), By Distribution Channel (Online Pharmacies , Retail Pharm

Incretin Mimetics Market, By Drug Type (Exenatide, Liraglutide, Sitagliptin, Saxagliptin, Alogliptin , Others), By Disease Indication (Type 2 Diabetes Mellitus (T2DM) , Weight Management , Others), By Distribution Channel (Online Pharmacies , Retail Pharmacies , Hospital Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).


Incretin mimetics are a class of drugs that mimic the effects of incretin hormones like GLP-1. Incretins are gut hormones that are released in response to eating and help stimulate insulin secretion. Incretin mimetics work by binding to and activating GLP-1 receptors. When triggered, these receptors stimulate the production and release of insulin from beta cells in a glucose-dependent manner. This leads to better control of blood sugar levels with a lower risk of hypoglycemia. In addition, incretin mimetics are also associated with weight loss due to reduced appetite and food intake. Some common Incretin mimetics drugs approved for treating type 2 diabetes include exenatide and liraglutide.

Market Dynamics:

The global incretin mimetics market’s growth is driven by the growing prevalence of type 2 diabetes worldwide, coupled with the increasing adoption of GLP-1 drugs over other classes of antidiabetic medications. Their efficacy in promoting weight loss and low risk of hypoglycemia give them an advantage compared to alternatives. However, factors such as high development costs, stringent regulatory pathways, and side effects associated with long-term usage of incretin mimetics could hamper market growth. Meanwhile, developing economies represent lucrative opportunities for market players attributed to improving access to healthcare facilities and diagnostics in these regions. Continuous research and development into novel delivery systems and longer-acting formulations also present new avenues for augmenting the market revenues over the forecast period.

Key Features of the Study:
  • This report provides an in-depth analysis of the global incretin mimetics market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global incretin mimetics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include GSK, Novo Nordisk, Lily, Haosoh, Sanofi, AstraZeneca, Pfizer Inc, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd and Sun Pharmaceutical Industries Ltd., Daiichi Sankyo Company, Limited, AbbVie Inc., Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Cadil Healthcare Ltd., Alembic Pharmaceuticals Limited and Boehringer Ingelheim
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global incretin mimetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global incretin mimetics market
Detailed Segmentation:
  • Drug Type:
  • Exenatide
  • Liraglutide
  • Sitagliptin
  • Saxagliptin
  • Alogliptin
  • Others
  • Disease Indication:
  • Type 2 Diabetes Mellitus (T2DM)
  • Weight Management
  • Others
  • Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profiles:
  • GSK
  • Novo Nordisk
  • Lily
  • Haosoh
  • Sanofi
  • AstraZeneca
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Daiichi Sankyo Company, Limited
  • AbbVie Inc.
  • Reddy’s Laboratories Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Cadila Healthcare Ltd.
  • Alembic Pharmaceuticals Limited
  • Boehringer Ingelheim


1. Research Objectives and Assumptions
Research Objectives
Assumptions
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot By Drug Type
Market Snapshot By Disease Indication
Market Snapshot By Distribution channel
Market Snapshot By Region
Market Scenario - Conservative, Like, Opportunistic
Market Opportunity Map
3. Key Insights
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals
4. Global Incretin Mimetics Market, By Drug Type, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Segment Trends
Exenatide, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Liraglutide, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Sitagliptin, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Saxagliptin, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Alogliptin, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Others, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
5. Global Incretin Mimetics Market, By Disease Indication, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Segment Trends
Type 2 Diabetes Mellitus (T2DM), 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Weight Management, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Others, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
6. Global Incretin Mimetics Market, By Distribution Channel, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Segment Trends
Hospital Pharmacies, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Retail Pharmacies, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
Online Pharmacies, 2019 - 2031 (USD Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (USD Billion)
7. Global Incretin Mimetics Market, By Region, 2019 - 2031 (USD Billion)
Introduction
Market Share Analysis, 2024 - 2031, (USD Billion)
Segment Trends
By Region
North America
Introduction
Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Distribution channel, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Country, 2019 - 2031, (USD Billion)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Distribution channel, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Country, 2019 - 2031, (USD Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Distribution channel, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Country, 2019 - 2031, (USD Billion)
China
India
Japan
Australia
South Korea
ASEAN
Rest Of Asia Pacific
Latin America
Introduction
Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Distribution channel, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Country, 2019 - 2031, (USD Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Distribution channel, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Country, 2019 - 2031, (USD Billion)
GCC
Israel
Rest Of The Middle East
Africa
Introduction
Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Distribution channel, 2019 - 2031, (USD Billion)
Market Size and Forecast, By Country,/Region 2019 - 2031, (USD Billion)
South Africa
North Africa
Central Africa
8. Company Profiles - Global Incretin Mimetics Market
GSK*
Company Overview
Product/Service Portfolio
Financial Performance
Recent Developments/Updates
Strategic Overview
Novo Nordisk
Lily
Haosoh
Sanofi
AstraZeneca
Pfizer Inc
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Daiichi Sankyo Company, Limited
AbbVie Inc.
Dr. Reddy's Laboratories Ltd.
Torrent Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd.
Alembic Pharmaceuticals Limited
Boehringer Ingelheim
9. References and Research Methodology
References
Research Methodology
About us and Sales Contact

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings